Global Companion Animal Pharmaceutical Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Companion Animal Pharmaceutical Market Size Growth Rate by Indication: 2016 VS 2021 VS 2027
  • 1.2.2 Infectious Diseases
  • 1.2.3 Dermatologic Diseases
  • 1.2.4 Pain
  • 1.2.5 Orthopedic Diseases
  • 1.2.6 Behavioral Diseases
  • 1.2.7 Other Indications
• 1.3 Market by Application
  • 1.3.1 Global Companion Animal Pharmaceutical Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Dogs
  • 1.3.3 Cats
  • 1.3.4 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Companion Animal Pharmaceutical Market Perspective (2016-2027)
• 2.2 Companion Animal Pharmaceutical Growth Trends by Regions
  • 2.2.1 Companion Animal Pharmaceutical Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Companion Animal Pharmaceutical Historic Market Share by Regions (2016-2021)
  • 2.2.3 Companion Animal Pharmaceutical Forecasted Market Size by Regions (2022-2027)
• 2.3 Companion Animal Pharmaceutical Industry Dynamic
  • 2.3.1 Companion Animal Pharmaceutical Market Trends
  • 2.3.2 Companion Animal Pharmaceutical Market Drivers
  • 2.3.3 Companion Animal Pharmaceutical Market Challenges
  • 2.3.4 Companion Animal Pharmaceutical Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Companion Animal Pharmaceutical Players by Revenue
  • 3.1.1 Global Top Companion Animal Pharmaceutical Players by Revenue (2016-2021)
  • 3.1.2 Global Companion Animal Pharmaceutical Revenue Market Share by Players (2016-2021)
• 3.2 Global Companion Animal Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Companion Animal Pharmaceutical Revenue
• 3.4 Global Companion Animal Pharmaceutical Market Concentration Ratio
  • 3.4.1 Global Companion Animal Pharmaceutical Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Companion Animal Pharmaceutical Revenue in 2020
• 3.5 Companion Animal Pharmaceutical Key Players Head office and Area Served
• 3.6 Key Players Companion Animal Pharmaceutical Product Solution and Service
• 3.7 Date of Enter into Companion Animal Pharmaceutical Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Animal Pharmaceutical Breakdown Data by Indication

• 4.1 Global Companion Animal Pharmaceutical Historic Market Size by Indication (2016-2021)
• 4.2 Global Companion Animal Pharmaceutical Forecasted Market Size by Indication (2022-2027)

5 Companion Animal Pharmaceutical Breakdown Data by Application

• 5.1 Global Companion Animal Pharmaceutical Historic Market Size by Application (2016-2021)
• 5.2 Global Companion Animal Pharmaceutical Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Companion Animal Pharmaceutical Market Size (2016-2027)
• 6.2 North America Companion Animal Pharmaceutical Market Size by Indication
  • 6.2.1 North America Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
  • 6.2.2 North America Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
  • 6.2.3 North America Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
• 6.3 North America Companion Animal Pharmaceutical Market Size by Application
  • 6.3.1 North America Companion Animal Pharmaceutical Market Size by Application (2016-2021)
  • 6.3.2 North America Companion Animal Pharmaceutical Market Size by Application (2022-2027)
  • 6.3.3 North America Companion Animal Pharmaceutical Market Size by Application (2016-2027)
• 6.4 North America Companion Animal Pharmaceutical Market Size by Country
  • 6.4.1 North America Companion Animal Pharmaceutical Market Size by Country (2016-2021)
  • 6.4.2 North America Companion Animal Pharmaceutical Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Companion Animal Pharmaceutical Market Size (2016-2027)
• 7.2 Europe Companion Animal Pharmaceutical Market Size by Indication
  • 7.2.1 Europe Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
  • 7.2.2 Europe Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
  • 7.2.3 Europe Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
• 7.3 Europe Companion Animal Pharmaceutical Market Size by Application
  • 7.3.1 Europe Companion Animal Pharmaceutical Market Size by Application (2016-2021)
  • 7.3.2 Europe Companion Animal Pharmaceutical Market Size by Application (2022-2027)
  • 7.3.3 Europe Companion Animal Pharmaceutical Market Size by Application (2016-2027)
• 7.4 Europe Companion Animal Pharmaceutical Market Size by Country
  • 7.4.1 Europe Companion Animal Pharmaceutical Market Size by Country (2016-2021)
  • 7.4.2 Europe Companion Animal Pharmaceutical Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Companion Animal Pharmaceutical Market Size (2016-2027)
• 8.2 Asia-Pacific Companion Animal Pharmaceutical Market Size by Indication
  • 8.2.1 Asia-Pacific Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
  • 8.2.2 Asia-Pacific Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
  • 8.2.3 Asia-Pacific Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
• 8.3 Asia-Pacific Companion Animal Pharmaceutical Market Size by Application
  • 8.3.1 Asia-Pacific Companion Animal Pharmaceutical Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Companion Animal Pharmaceutical Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Companion Animal Pharmaceutical Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Companion Animal Pharmaceutical Market Size by Region
  • 8.4.1 Asia-Pacific Companion Animal Pharmaceutical Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Companion Animal Pharmaceutical Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Companion Animal Pharmaceutical Market Size (2016-2027)
• 9.2 Latin America Companion Animal Pharmaceutical Market Size by Indication
  • 9.2.1 Latin America Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
  • 9.2.2 Latin America Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
  • 9.2.3 Latin America Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
• 9.3 Latin America Companion Animal Pharmaceutical Market Size by Application
  • 9.3.1 Latin America Companion Animal Pharmaceutical Market Size by Application (2016-2021)
  • 9.3.2 Latin America Companion Animal Pharmaceutical Market Size by Application (2022-2027)
  • 9.3.3 Latin America Companion Animal Pharmaceutical Market Size by Application (2016-2027)
• 9.4 Latin America Companion Animal Pharmaceutical Market Size by Country
  • 9.4.1 Latin America Companion Animal Pharmaceutical Market Size by Country (2016-2021)
  • 9.4.2 Latin America Companion Animal Pharmaceutical Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Companion Animal Pharmaceutical Market Size (2016-2027)
• 10.2 Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication
  • 10.2.1 Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
  • 10.2.2 Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
  • 10.2.3 Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
• 10.3 Middle East & Africa Companion Animal Pharmaceutical Market Size by Application
  • 10.3.1 Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country
  • 10.4.1 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Zoetis
  • 11.1.1 Zoetis Company Details
  • 11.1.2 Zoetis Business Overview
  • 11.1.3 Zoetis Companion Animal Pharmaceutical Introduction
  • 11.1.4 Zoetis Revenue in Companion Animal Pharmaceutical Business (2016-2021)
  • 11.1.5 Zoetis Recent Development
• 11.2 Boehringer Ingelheim
  • 11.2.1 Boehringer Ingelheim Company Details
  • 11.2.2 Boehringer Ingelheim Business Overview
  • 11.2.3 Boehringer Ingelheim Companion Animal Pharmaceutical Introduction
  • 11.2.4 Boehringer Ingelheim Revenue in Companion Animal Pharmaceutical Business (2016-2021)
  • 11.2.5 Boehringer Ingelheim Recent Development
• 11.3 Merck Animal Health
  • 11.3.1 Merck Animal Health Company Details
  • 11.3.2 Merck Animal Health Business Overview
  • 11.3.3 Merck Animal Health Companion Animal Pharmaceutical Introduction
  • 11.3.4 Merck Animal Health Revenue in Companion Animal Pharmaceutical Business (2016-2021)
  • 11.3.5 Merck Animal Health Recent Development
• 11.4 Elanco Animal Health
  • 11.4.1 Elanco Animal Health Company Details
  • 11.4.2 Elanco Animal Health Business Overview
  • 11.4.3 Elanco Animal Health Companion Animal Pharmaceutical Introduction
  • 11.4.4 Elanco Animal Health Revenue in Companion Animal Pharmaceutical Business (2016-2021)
  • 11.4.5 Elanco Animal Health Recent Development
• 11.5 Bayer Animal Health
  • 11.5.1 Bayer Animal Health Company Details
  • 11.5.2 Bayer Animal Health Business Overview
  • 11.5.3 Bayer Animal Health Companion Animal Pharmaceutical Introduction
  • 11.5.4 Bayer Animal Health Revenue in Companion Animal Pharmaceutical Business (2016-2021)
  • 11.5.5 Bayer Animal Health Recent Development
• 11.6 Virbac
  • 11.6.1 Virbac Company Details
  • 11.6.2 Virbac Business Overview
  • 11.6.3 Virbac Companion Animal Pharmaceutical Introduction
  • 11.6.4 Virbac Revenue in Companion Animal Pharmaceutical Business (2016-2021)
  • 11.6.5 Virbac Recent Development
• 11.7 Dechra Veterinary Products
  • 11.7.1 Dechra Veterinary Products Company Details
  • 11.7.2 Dechra Veterinary Products Business Overview
  • 11.7.3 Dechra Veterinary Products Companion Animal Pharmaceutical Introduction
  • 11.7.4 Dechra Veterinary Products Revenue in Companion Animal Pharmaceutical Business (2016-2021)
  • 11.7.5 Dechra Veterinary Products Recent Development
• 11.8 Ceva
  • 11.8.1 Ceva Company Details
  • 11.8.2 Ceva Business Overview
  • 11.8.3 Ceva Companion Animal Pharmaceutical Introduction
  • 11.8.4 Ceva Revenue in Companion Animal Pharmaceutical Business (2016-2021)
  • 11.8.5 Ceva Recent Development
• 11.9 Vetoquinol
  • 11.9.1 Vetoquinol Company Details
  • 11.9.2 Vetoquinol Business Overview
  • 11.9.3 Vetoquinol Companion Animal Pharmaceutical Introduction
  • 11.9.4 Vetoquinol Revenue in Companion Animal Pharmaceutical Business (2016-2021)
  • 11.9.5 Vetoquinol Recent Development
• 11.10 Meiji
  • 11.10.1 Meiji Company Details
  • 11.10.2 Meiji Business Overview
  • 11.10.3 Meiji Companion Animal Pharmaceutical Introduction
  • 11.10.4 Meiji Revenue in Companion Animal Pharmaceutical Business (2016-2021)
  • 11.10.5 Meiji Recent Development
• 11.11 Ouro Fino Saude
  • 11.11.1 Ouro Fino Saude Company Details
  • 11.11.2 Ouro Fino Saude Business Overview
  • 11.11.3 Ouro Fino Saude Companion Animal Pharmaceutical Introduction
  • 11.11.4 Ouro Fino Saude Revenue in Companion Animal Pharmaceutical Business (2016-2021)
  • 11.11.5 Ouro Fino Saude Recent Development
• 11.12 Parnell
  • 11.12.1 Parnell Company Details
  • 11.12.2 Parnell Business Overview
  • 11.12.3 Parnell Companion Animal Pharmaceutical Introduction
  • 11.12.4 Parnell Revenue in Companion Animal Pharmaceutical Business (2016-2021)
  • 11.12.5 Parnell Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer